| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,034 |
16,765 |
$962K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,694 |
8,324 |
$722K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,009 |
863 |
$263K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,139 |
3,589 |
$254K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,393 |
3,207 |
$200K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,871 |
1,707 |
$178K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,690 |
2,381 |
$167K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,678 |
2,469 |
$159K |
| 87631 |
|
1,221 |
1,067 |
$99K |
| 99215 |
Prolong outpt/office vis |
1,083 |
909 |
$94K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,257 |
1,191 |
$77K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,828 |
1,569 |
$48K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
431 |
408 |
$40K |
| 80061 |
Lipid panel |
3,219 |
2,964 |
$23K |
| 90670 |
|
1,987 |
1,866 |
$20K |
| 92081 |
|
1,813 |
1,655 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
456 |
355 |
$15K |
| 90680 |
|
1,466 |
1,376 |
$14K |
| 90648 |
|
1,539 |
1,447 |
$13K |
| 90686 |
|
1,492 |
1,405 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
595 |
506 |
$12K |
| 98966 |
|
1,112 |
918 |
$11K |
| 36416 |
|
4,625 |
4,304 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
884 |
845 |
$11K |
| 99443 |
|
210 |
200 |
$10K |
| 90633 |
|
1,210 |
1,130 |
$10K |
| 99460 |
|
152 |
142 |
$10K |
| 93320 |
|
463 |
437 |
$10K |
| 90723 |
|
1,000 |
942 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
845 |
759 |
$9K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
136 |
132 |
$9K |
| 99442 |
|
285 |
252 |
$9K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
100 |
70 |
$8K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
498 |
479 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,192 |
996 |
$7K |
| 99174 |
|
3,396 |
2,423 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
687 |
251 |
$6K |
| 85018 |
|
4,853 |
4,501 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
724 |
654 |
$6K |
| 99354 |
|
126 |
119 |
$6K |
| 82962 |
|
2,829 |
2,605 |
$5K |
| 83655 |
|
719 |
694 |
$5K |
| 90688 |
|
583 |
525 |
$5K |
| 90698 |
|
378 |
360 |
$4K |
| 98967 |
|
436 |
325 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
509 |
449 |
$4K |
| 93325 |
|
359 |
334 |
$4K |
| 90651 |
|
498 |
455 |
$3K |
| 81002 |
|
1,872 |
1,708 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
65 |
63 |
$3K |
| 90700 |
|
313 |
296 |
$3K |
| 0001A |
|
127 |
100 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
353 |
288 |
$3K |
| 90710 |
|
333 |
317 |
$2K |
| 87428 |
|
76 |
49 |
$2K |
| 92567 |
|
369 |
337 |
$2K |
| 96127 |
|
730 |
580 |
$2K |
| G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) |
97 |
83 |
$2K |
| 90707 |
|
214 |
193 |
$2K |
| 0002A |
|
78 |
70 |
$2K |
| 99383 |
|
29 |
28 |
$2K |
| 99381 |
|
24 |
24 |
$2K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$2K |
| 90672 |
|
198 |
193 |
$2K |
| 87807 |
|
411 |
385 |
$2K |
| 90656 |
|
498 |
480 |
$2K |
| 99382 |
|
18 |
18 |
$2K |
| 87634 |
|
35 |
32 |
$2K |
| 0072A |
|
55 |
54 |
$2K |
| 90716 |
|
135 |
130 |
$1K |
| 99201 |
|
58 |
54 |
$1K |
| 90461 |
|
162 |
155 |
$1K |
| 0071A |
|
41 |
38 |
$1K |
| 90677 |
|
305 |
285 |
$1K |
| 99072 |
|
1,721 |
1,064 |
$1K |
| 99499 |
|
91 |
88 |
$959.74 |
| 90474 |
|
94 |
89 |
$830.96 |
| 90696 |
|
135 |
127 |
$825.11 |
| 90734 |
|
89 |
73 |
$721.94 |
| 99173 |
|
490 |
472 |
$634.71 |
| 90687 |
|
103 |
87 |
$508.21 |
| 90715 |
|
26 |
24 |
$318.79 |
| 94375 |
|
15 |
14 |
$261.03 |
| 90744 |
|
20 |
14 |
$251.28 |
| 90620 |
|
29 |
27 |
$184.92 |
| 99188 |
|
65 |
63 |
$159.00 |
| 94760 |
|
492 |
403 |
$142.14 |
| 90619 |
|
56 |
56 |
$121.87 |
| 93000 |
|
14 |
14 |
$58.45 |
| 94664 |
|
38 |
35 |
$32.46 |
| 96161 |
|
179 |
164 |
$25.65 |
| 94761 |
|
44 |
38 |
$17.15 |
| 96160 |
|
55 |
48 |
$12.34 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
37 |
29 |
$2.48 |
| 99000 |
|
13 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
31 |
29 |
$0.00 |
| 87581 |
|
14 |
14 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
14 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
15 |
14 |
$0.00 |